Healthcare professionals > Research and education
Research and education
Up to one in every five adults1 has sleep-disordered breathing (SDB).
An expanding body of scientific evidence clearly indicates that SDB has a profound negative impact on public health.
Through its strong partnership with the global medical community, ResMed is committed to:
- Increasing awareness of the dangers of untreated SDB
- Supporting ongoing research into the correlation of SDB with other health risks
- Finding effective clinical solutions to improve the health and lives of SDB patients
At ResMed, we are focused on developing our industry and patient expertise in sleep and respiratory disorders. That’s why we continue to research areas related to sleep-disordered breathing.
Sleep apnoea and cardiovascular issues
Further explore research topics on cardiovascular disease and its connection to sleep apnoea and SDB.
Diabetes and sleep apnoea
Explore research about diabetes in relation to sleep and respiratory care.
Obesity and sleep apnoea
Obesity and sleep apnoea is highly prevalent in morbidly obese patients and is associated with increased risk of cardiac arrhythmias
Sleep-related traffic and occupational accidents
Obstructive sleep apnoea (OSA) sufferers have a significantly increased risk of motor vehicle accidents.
Sleep-disordered breathing and positive airway pressure
Read more research on the topics of sleep-disordered breathing (SDB) and positive airway pressure (PAP).
Sleep therapy compliance
Read about research on compliance in relation to positive airway pressure therapy.
Changes in sleep stage, weight, body position, and other factors can alter a patient's airway pressure treatment requirements from night to night, hour to hour and breath to breath.
Screening for Obstructive Sleep Apnoea (OSA)
ResMed offers several solutions to screen and diagnose Obstructive Sleep Apnoea (OSA). Discover the ways to screen OSA at home and in different care settings.
Non-Invasive Ventilation for paediatric patients
Children with inherited neuromuscular conditions have a high risk of respiratory disorders during early childhood or adolescence. Non-Invasive Ventilation (NIV) is recommended to improve quality of life.
Non-Invasive Ventilation for COPD patients
Treatment of COPD with non-invasive ventilation (NIV) has been shown to be effective in treating acute exacerbations of COPD, assisting pulmonary rehabilitation in COPD patients, and providing benefits in managing chronic hypercapnic COPD patients.
Non-Invasive Ventilation for obesity hypoventilation syndrome
Non-invasive ventilation in patients with obesity hypoventilation syndrome has been shown to normalise blood gases, prolong survival and increase exercise capacity.
Non-Invasive Ventilation for neuromuscular diseases in adults
Many chronic neuromuscular disorders lead to progressive respiratory muscle dysfunction. Non-invasive ventilation can help reduce daytime sleepiness while facilitating gas exchange and breathing.
ResMed develops ventilators using the latest iVAPS technology that continuously adapts to patients for a more comfortable respiratory therapy experience.
Non-Invasive Ventilation for acute respiratory failure
Non-invasive ventilation (NIV) is often used for patients with Chronic Obstructive Pulmonary Disease, but emerging evidence suggests that NIV can be used in treating other types of acute respiratory failure.
Farrell Historical Landmarks
ResMed Founder and Chairman Dr. Peter Farrell identifies key research findings that are shaping the field of sleep medicine today.
ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives in five associated areas of clinical focus related to sleep-disordered breathing.
Cardiology research at ResMed
ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to cardiology.
Chronic Obstructive Pulmonary Disease (COPD) research at ResMed
Obstructive Sleep Apnoea (OSA) and chronic obstructive pulmonary disease (COPD) often coexist within a patient. Learn more about overlap syndrome on our research initiative page.
Clinical results for Narval CC™ – the ORCADES study
The 5-year multicentre ORCADES study demonstrated both the efficacy and compliance of the Narval CC™ MRD.
Diabetes research at ResMed
ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to type 2 diabetes.
Occupational health and safety research at ResMed
ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to occupational health and safety.
Peri-operative care research at ResMed
ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to peri-operative care.
Other research at ResMed
ResMed is dedicated to innovating and changing lives. We support and actively engage in research initiatives related to sleep-disordered breathing.
We believe that industry and medical science must work together to enhance medicine and patient therapy. Our acclaimed sleep program was developed in support of this philosophy.
ResMed Academy Online
ResMed Academy Online is designed to provide healthcare professionals and medical equipment professionals with easy access to a variety of learning resources. Learners can enroll in online courses, complete learning activities, and track the progress of their online course completion in the comfort of their home or work. ResMed Academy Online may enhance the care you provide by keeping you updated on the new applications, emerging technology, and insights into new techniques in sleep medicine and respiratory care.
Education & Training
We believe that industry and the medical community must work together to optimise medicine and patient therapy. Our acclaimed sleep and ventilation training programs were developed in support of this philosophy.